Evidence map›Paper›PMID 39981498›Full record

ArticlePractical laboratory medicine2025

Preparation of recombinant myoglobin and investigation of the liquid antigen stability for quality control materials.

Yu-Hui Wang, Xi-Feng Sun, Chun-Xin Xu, Feng-Qiang Sun, Rong-Rong Wang, Xiao-Kun Bian, Zhan-Zhao Wang, Qiang Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Practical laboratory medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yu-Hui WangClinical Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang, 261000, Shandong, China.
Xi-Feng SunClinical Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang, 261000, Shandong, China.
Chun-Xin XuClinical Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang, 261000, Shandong, China.
Feng-Qiang SunClinical Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang, 261000, Shandong, China.
Rong-Rong WangClinical Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang, 261000, Shandong, China.
Xiao-Kun BianClinical Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang, 261000, Shandong, China.
Zhan-Zhao WangClinical Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang, 261000, Shandong, China.
Qiang WuClinical Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang, 261000, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myoglobin (Mb) has been used as a biomarker for acute myocardial infarction. This study aimed to evaluate the stability of liquid Mb as quality control materials for Mb determination. Mb protein was expressed in

Indexed as

Escherichia coli expression systemImmunoreactivityQuality control materialRecombinant myoglobinStorage stability

Identifiers

PMID39981498
PMCPMC11840484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.